Skip to content

New clinical application for retinoic acid levels

New clinical application for retinoic acid levels

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089599
Enrollment
Unknown
Registered
2024-09-11
Start date
2024-09-16
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular calcification

Interventions

Observation group:None

Sponsors

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with clinically suspected or confirmed coronary artery disease underwent dual-source CT (plain) of the chest, which was classified as having no or mild coronary calcification and moderate-to-severe coronary calcification based on the coronary calcification score. Subjects were aged 40 to 80 years.

Exclusion criteria

Exclusion criteria: Patients with coronary artery disease who had been treated with PCI, patients with ACS who were not candidates for dual-source CT (plain) of the chest prior to intervention; patients who did not wish to participate in this study; patients with missing data; patients with a combination of other vasculogenic calcification factors; and patients who were involved in other clinical studies in the last three months.

Design outcomes

Primary

MeasureTime frame
ATRA(retinoic acid);LAMIN A/C;CXCL13;

Countries

China

Contacts

Public ContactMeng Shu

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

msdoctor@126.com+86 139 1600 5250

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026